Pregnancy Induced Hypertension Clinical Trial
Official title:
Effects of Breathing Control vs Alternate Nostril Breathing on Maternal Cardiovascular Parameters in Pregnancy Induced Hypertension
Verified date | August 2023 |
Source | Riphah International University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To determine the effects of Breathing control vs Alternate nostril breathing on maternal cardiovascular parameters in pregnancy and to determine the effect of breathing control vs Alternate nostril breathing on Fetal Heart rate. Many evidence-based studies show breathing exercises have beneficial and useful effects on the hypertensive population and also have positive effects on pregnancy-induced hypertension.
Status | Completed |
Enrollment | 46 |
Est. completion date | August 30, 2023 |
Est. primary completion date | August 30, 2023 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 35 Years |
Eligibility | Inclusion Criteria: - Females with 3rd-trimester pregnancies included - BMI<3 - Diagnosed pregnancy-induced HTN Exclusion Criteria: - An exaggerated response to exercise on BP ( 160/110 mmHg ) - Uncontrolled Diabetics or asthma - Cardiac diseases - Orthopedic complications - Using anti-epileptic drugs and - Hyperthyroidism or hypothyroidism |
Country | Name | City | State |
---|---|---|---|
Pakistan | Punjab medical center Gujarat. | Gujrat | Punjab |
Lead Sponsor | Collaborator |
---|---|
Riphah International University |
Pakistan,
Aalami M, Jafarnejad F, ModarresGharavi M. The effects of progressive muscular relaxation and breathing control technique on blood pressure during pregnancy. Iran J Nurs Midwifery Res. 2016 May-Jun;21(3):331-6. doi: 10.4103/1735-9066.180382. — View Citation
Felton M, Hundley VA, Grigsby S, McConnell AK. Effects of slow and deep breathing on reducing obstetric intervention in women with pregnancy-induced hypertension: a feasibility study protocol. Hypertens Pregnancy. 2021 Feb;40(1):81-87. doi: 10.1080/10641955.2020.1869250. Epub 2021 Jan 19. — View Citation
Tsakiridis I, Bakaloudi DR, Oikonomidou AC, Dagklis T, Chourdakis M. Exercise during pregnancy: a comparative review of guidelines. J Perinat Med. 2020 Jul 28;48(6):519-525. doi: 10.1515/jpm-2019-0419. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood Pressure | Changes from baseline to 4 weeks after the intervention, time of discharge from the hospital, and, 40 days postpartum, measured through a sphygmomanometer. Blood pressure is measured in millimeters of mercury (mm Hg). A blood pressure measurement has two numbers Systolic and Diastolic. The patients are classified according to the range as follows. Hypertension stage 1 SYSTOLIC (mm of Hg): 131-139, DIASTOLIC (mm of Hg): 81-89 and stage 2 SYSTOLIC (mm of Hg): 140 and above, DIASTOLIC (mm of Hg): 90 and above | 12 weeks | |
Primary | Oxygen Saturation | Changes from baseline to 4 weeks after the intervention, time of discharge from the hospital, and, 40 days postpartum, measured through a pulse oximeter. It measures how much oxygen is in person's blood. It is a small device, clips onto a finger, earlobe or another part of the body. Oxygen saturation level of 95% is considered typical for most healthy people, a level of 92% or lower can indicate potential hypoxemia, which is a seriously low level of oxygen in the blood. | 12 weeks | |
Primary | Functional capacity | Changes from baseline to 4 weeks after the intervention, and, 40 days postpartum, measured through 6 min walk test (6 MWT) used to measure Functional capacity. It is a submaximal exercise test that can aid in assessing the functional capacity of patients with cardiopulmonary diseases, in this test we find out the maximum distance in meters that an individual covers in 6 min without any support. | 12 weeks | |
Primary | Quality of life(QOL) (postpartum) | Changes from baseline to 4 weeks after intervention and 40 days postpartum measured through Short Form 36 Health Survey Questionnaire (SF-36) that is used to indicate the health status of particular population. Its consists of eight scaled scores, which are weighted sums of the questions in each section. Each scale is directly transformed into a 0-100 scale on assumption that every question carries equal weight and lower score the more disability. | 12 weeks | |
Secondary | Fetal Heart rate | Changes from baseline to Changes from baseline to 4 weeks after intervention and time of delivery measured through Doppler ultrasound (US).This is a method that uses a device to listen and record heartbeat of baby through abdomen. The rate and pattern of heart rate of baby shown on a screen and printed on paper. The average fetal heart rate is between 110 and 160 beats per minute. | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04286217 -
SD-OCT Measurement of the Human Retina in Pregnancy With Pre-existing or De Novo Hypertension and Without Hypertension
|
||
Recruiting |
NCT04604535 -
The BEET-BP Trial - Investigating the Effect of Dietary Nitrates on Hypertension in Pregnancy
|
N/A | |
Recruiting |
NCT04508582 -
Cardiac and Immune Cell Function in Preeclampsia
|
||
Not yet recruiting |
NCT06248463 -
Blood Pressure Assessment in Waiting Room During Pregnancy
|
||
Suspended |
NCT01519297 -
Preeclampsia: A Marker for Future Cardiovascular Risk in Women
|
N/A | |
Completed |
NCT01682304 -
Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension
|
||
Recruiting |
NCT02016638 -
Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes
|
N/A | |
Recruiting |
NCT05009433 -
HIIT vs MICT During Pregnancy and Health and Birth Outcomes in Mothers and Children
|
N/A | |
Withdrawn |
NCT00293735 -
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT05434195 -
Clinical Antenatal Randomised Study to CharactErise Key Roles of TetrahydroFOLate in HyperTensive Pregnancies
|
N/A | |
Completed |
NCT04421183 -
Investigation of the Serum Mucoprotein 3 (MUC3) Protein Levels in Gestational Hypertensive Disease
|
||
Suspended |
NCT04979793 -
Role of L-citrulline in Prevention of Pregnancy Associated Hypertension
|
Phase 1 | |
Recruiting |
NCT05955040 -
Treatment of Elevated Blood Pressures in Early Pregnancy
|
Phase 2 | |
Completed |
NCT04943133 -
Concordance Between the Systolic Foot-to-Apex Interval and the Auscultatory Method for Measuring Brachial Systolic Pressure in Pregnant Women With or Without Blood Pressure Disorders and Search for Markers of Arterial Stiffness in Pre-eclampsia.
|
N/A | |
Not yet recruiting |
NCT02007837 -
Prospects for the Prevention of Pregnancy-induced Hypertension and Preeclampsia Trial
|
Phase 3 | |
Completed |
NCT02229526 -
Fish Oil Trials in Pregnancy for the Prevention of Pregnancy Complications ('FOTIP')
|
N/A | |
Completed |
NCT03693638 -
Fractionated Vs Single Dose Injection for Spinal C-Section in Patients With Pregnancy-Induced Hypertension
|
N/A | |
Completed |
NCT02213094 -
Phase I Study of Nicotinamide for Early Onset Preeclampsia
|
Phase 1 | |
Recruiting |
NCT06340152 -
Multi-Omics for Maternal Health After Preeclampsia
|
||
Completed |
NCT05073978 -
B-vitamin Levels and Adverse Pregnancy Outcomes
|